FDA Infant Formula Registration: Why Foreign Manufacturers Face the Strictest US Import Requirements

Infant formula is the most strictly regulated food category in the United States. No other food product faces the combination of premarket notification requirements, mandatory nutrient specifications, quality control mandates, and recall preparedness obligations that the FDA imposes on infant formula. For foreign manufacturers seeking to export infant formula to the United States, the regulatory pathway is significantly more complex and costly than for any other food product — and the consequences of non-compliance are correspondingly severe, including automatic detention, import refusal, and potential criminal prosecution.

Premarket notification under 21 CFR 106.120

Before any new infant formula can be marketed in the United States, the manufacturer must submit a premarket notification to the FDA at least 90 days before introducing the product. This is not a standard food facility registration — it is a product-specific submission that must demonstrate that the formula will provide adequate nutrition and will not present a health risk to infants. The notification must include the quantitative formulation of the product, a description of all processing steps, stability data demonstrating that nutrient levels remain adequate throughout the shelf life, evidence that the formula supports healthy growth in infants, and a description of the quality control procedures used during manufacturing. The FDA reviews the notification and may request additional information, studies, or modifications before allowing the formula to be marketed.

Mandatory nutrient requirements under 21 CFR 107.100

21 CFR 107.100 specifies the minimum and maximum levels of 29 nutrients that must be present in infant formula. These include protein, fat, essential fatty acids (linoleic acid), vitamins A through K, B vitamins (thiamine, riboflavin, B6, B12, niacin, folic acid, pantothenic acid, biotin), minerals (calcium, phosphorus, magnesium, iron, zinc, manganese, copper, iodine, sodium, potassium, chloride), and choline. The minimum levels represent the amounts necessary to support infant growth and development, while maximum levels (where specified) represent safety limits above which adverse effects may occur. Every batch of infant formula must be tested to verify that nutrient levels fall within these ranges, and the manufacturer must maintain records demonstrating compliance for every batch distributed.

Quality control requirements under 21 CFR Part 106

21 CFR Part 106 establishes detailed quality control requirements specific to infant formula that go far beyond the CGMP requirements for other food categories. Manufacturers must test each batch of formula for all required nutrients, for pathogenic organisms, for physical contaminants, and for compliance with the product's specifications. Manufacturing process controls must be validated to ensure consistency, and any deviation from the validated process must be investigated, documented, and reported. The manufacturer must also maintain comprehensive records of all testing, investigations, and corrective actions, and these records must be available to the FDA on request.

Recall preparedness and adverse event reporting

Infant formula manufacturers must have a written recall plan in place before marketing begins. The recall plan must describe the procedures for initiating and conducting a recall, including identification of affected product, notification of distributors and retailers, public notification procedures, and procedures for collecting, segregating, and disposing of recalled product. The manufacturer must also report to the FDA any adverse event that may be associated with the use of the formula, and must report any instance in which a batch of formula does not meet the quality factor specifications or the nutrient requirements. These reporting obligations are mandatory and time-sensitive — failure to report can result in criminal prosecution.

Barriers to entry for foreign manufacturers

The combination of premarket notification, mandatory nutrient testing, quality control requirements, and recall preparedness creates a significant barrier to entry for foreign infant formula manufacturers. Many foreign manufacturers that successfully export infant formula to European, Asian, and Middle Eastern markets find that the US requirements are substantially more demanding — the EU framework, for example, is comprehensive but structured differently, and compliance with EU Regulation 609/2013 does not automatically satisfy FDA requirements. Foreign manufacturers must also navigate US-specific labeling requirements (including a Nutrition Facts format specific to infant formula), US Agent and facility registration requirements, and the practical challenge of demonstrating to the FDA that their quality control systems meet the standards in 21 CFR Part 106.

How FDABridge advises infant formula manufacturers

FDABridge provides FDA food facility registration and US Agent services for foreign infant formula manufacturers. While the premarket notification and quality control compliance for infant formula require specialized regulatory expertise, FDABridge ensures that your facility registration, DUNS number, and US Agent designation are properly established as the foundation for your infant formula market entry. Visit fdabridge.com/food to learn about our food registration services or fdabridge.com/contact to discuss your compliance needs.